0% found this document useful (0 votes)
22 views29 pages

Understanding Drug Receptors and Interactions

Uploaded by

Urvashi
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
22 views29 pages

Understanding Drug Receptors and Interactions

Uploaded by

Urvashi
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd

MPL102T-Seminar

Presented by,
K ACHYUTH
[Link] 1st Year
Advanced Pharmacology-1
Department of Pharmacology
MSRUAS
What are RECEPTORS?

• Definition;
It is defined as a macromolecule or binding site located on the surface
or inside the effector cell that serves to recognize the signal molecule
or a drug and initiate the response to it.
• Itself has no other function.
• These are the proteins located on the cell or inside the cell
• It helps in transmitting the signals from outside the cell to the inside
the side.
• The word ‘receptor’ was given by Paul Ehrlich (1854- 1915).

2
Terms used in Drug-Receptor interaction

• Affinity: Refers to the strength of the interaction between a drug and


its receptor.
• Efficacy: refers to the ability of a drug to produce a biological
response, such as opening or closing an ion channel, activating an
enzyme, or regulating gene expression.
• Agonist: a drug that binds to a receptor and activates it to produce a
biological response.
• Antagonist: a drug which prevents the action of an agonist on a
receptor from producing biological response.
• Inverse agonist : a drug which activates the receptors to produce a
effect in the opposite direction to that of the agonist. 3
Cont.…

• Partial agonist : a drug which activates a receptor to produce


submaximal effect but antagonizes the action of a full agonist.

4
Agonists
E=+1

Partial
Agonists

E= 0 Antagonists

Inverse
Agonists
E= -1
RECEPTOR FAMILIES
CLASSIFICATION OF RECEPTORS

[Link] RECEPTORS
a) Ligand gated ion channels (Ionotropic receptors).
b) G-Protein coupled receptors.
c) Enzyme linked receptors.
2. INTRACELLULAR RECEPTORS
a) Nuclear receptors

6
G-PROTEIN COUPLED RECEPTORS:
• These receptors are comprised of single peptide that has seven
membrane spanning regions and hence they are called SEVEN-
TRANSMEMBRANE RECEPTORS.
• These comprises largest family of receptors.
• LOCATION : Localised on the cell membrane.
• TIMESCALE: Seconds.
• EFFECTOR: Enzymes and ion channels.
• COUPLING: G-PROTEIN
• EXAMPLE: Adrenergic receptors, Muscarinic Ach receptor, histaminic
receptors, opioid and cannabinoid receptors, 5-HT receptors etc
7
• G proteins also known as guanine nucleotide-binding proteins,
are a family of proteins that act as molecular switches inside
cells.
• G-proteins activity is regulated by its ability to hydrolyze guanosine
triphosphate(GTP) to guanosine di-phosphate(GDP).
• When they are bound to GDP they are ‘OFF’ and when they are
bound to GTP they are ‘ON’
• When the GPCRs binds to a signal molecule, the receptor is
• activated and changes its shape.
• This in turn send signals to G-proteins which causes displacement of GDP by GTP
which in turn activates G-protein.
• Activation causes the α-subunit to dissociate from the β and γ subunits .
• The α-subunit may bind to effector enzymes like adenylate cyclase and
phospholipase C.
• The β and γ sub-units binds to the ion channel kinases
TYPES OF G-PROTEIN COUPLED
RECEPTORS:

10
G-PROTEIN MEDIATED PATHWAYS

• SECONDARY MESSENGER SYSTEMS INVOLVED IN SIGNAL


TRANSDUCTION:
Adenylate cyclase c AMP mediated pathway.
Phospholipase mediated pathway.

11
Adenylate cyclase cAMP mediated pathway

• Adenylate cyclase is a membrane bound enzyme.


• These are activated by Gs proteins and are inactivated by Gi proteins.
• It produces cAMP using ATP, which acts on the protein kinases (PKA).
• The catalytic subunits are activated and carry out transcription
process
• In contrast to cAMP, the cGMP serves as an intracellular second
messenger only in a limited number of tissues, such as vascular
smooth muscle, intestinal mucosal cell and kidney.

12
Phospholipase C: IP3-DAG pathway
• The activated GTP-carrying α subunit of Gq activates the phospholipase Cβ (PLcβ).
• It hydrolyses the membrane phospholipid phosphatidyl inositol 4,5-bisphosphate
(PIP2 ) to generate the second messengers inositol 1,4,5-trisphosphate (IP3 ) and
diacylglycerol (DAG).
• The IP3 being water soluble diffuses to the cytosol and mobilizes Ca2+ from
endoplasmic reticular depots.
• The lipophilic DAG remains within the membrane, but recruits protein kinase C
(PKc) and activates it with the help of Ca2+.
• released Ca2+ acts as a highly versatile regulator acting through calmodulin
(CAM), PKc and other effectors—mediates/modulates smooth muscle,
contraction, glandular secretion, neuronal excitability, intracellular movements,
membrane function, metabolism, cell proliferation, etc 15
Ion channel receptor

• They are also known as ‘Ionotropic receptors’.


• LOCATION : Localised on the cell membrane.
• TIMESCALE: Milliseconds.
• EFFECTOR: ion channels.
• COUPLING: no coupling (direct acting)
• Ions include: Na+, K+, Ca2+, cl -
• EXAMPLE: Nicotinic Ach receptor, GABA receptors, Glutamate
receptors, Glycine receptors, 5-HT receptors.

17
Cont.…

• They give response to a binding chemical substance which in turn


called as LIGAND.
• When the ligand binds to the ion channel the receptor shows
confirmational changes in the structure and hence opens the way for
the influx of the ions.
• Influx of ‘+’ve ion causes depolarization.
• The influx of ‘–’ve ion causes polarization , repolarization and
hyperpolarization

18
Cont…

Signal molecule binds as a ligand at


a specific site on the receptor

Conformational changes open the


channel allowing ions to flow into
the cell

The change in ion concentration


within the cell triggers cellular
responses
19
Enzyme linked receptors

• An enzyme-linked receptor, also known as a catalytic receptor.


• Examples of the enzymatic activity include : Receptor tyrosine kinase.
In few cases it can also be guanylyl cyclase.
• LOCATION : Localized on the cell membrane.
• TIMESCALE: Few minutes to few hours.
• EFFECTOR: Protein kinases.
• COUPLING: no coupling (direct acting).
• EXAMPLE: Insulin, Growth factors, cytokine, ANF(atrial-natriuretic
factor) receptors.
20
STRUCTURE OF RECEPTOR
TYROSINE KINASE
• Receptors exist as individual polypeptides
• Each has an extracellular signal-binding site
• An intracellular tail with a number of tyrosine's
& a single α helix spanning the membrane.
• The signaling molecule binds to the receptor
on the outside of the cell and causes a
conformational change on the catalytic function
located on the receptor inside the cell

21
NUCLEAR RECEPTORS:
• A class of proteins found within cells that are responsible for the regulation of
transcription in response to small lipophilic compounds.
• They have ability to directly bind to DNA and regulate the adjacent genes.
• Nuclear receptors play key roles in both embryonic development and adult
homeostasis.
• LOCATION : Intracellular.
• TIMESCALE: minutes to hours.
• EFFECTOR: Gene transcription.
• COUPLING: via DNA.
• EXAMPLE: Steroid hormone, Thyroid hormone, Retinoic acid and vitamin D
receptors
23
STRUCTURE OF NUCLEAR RECEPTOR

1.(AB) N terminal regulator domain :


Contains the activation function 1 whose
action is independent of the presence of ligand.
2. (C)DNA binding domain(DBD):Highly
conserved
domain containing 2 zinc fingers that binds
to specific sequences of DNA called
hormone response elements(HRE)

24
Cont.…
• (D) Hinge region : flexible domain that connects the DBD with the
LBD,it influences intracellular trafficking and subcellular distribution.
• (E)Ligand binding domain(LBD) : Moderately conserved in a sequence
and highly conserved in structure b/w various nuclear receptors.

25
Functions of RECEPTORS

To propagate regulatory signals from outside to inside the effector


cell when the molecular species carrying the signal cannot itself
penetrate the cell membrane
To amplify the signal
To integrate various extracellular and intracellular regulatory signals
To adapt to short term and long term changes and to maintain
homeostasis.

27
Summery

28
PL102T-Seminar

You might also like